Nicholas Amoroso to Drug-Eluting Stents
This is a "connection" page, showing publications Nicholas Amoroso has written about Drug-Eluting Stents.
Connection Strength
0.545
-
Outcomes with various drug-eluting or bare metal stents in patients with ST-segment-elevation myocardial infarction: a mixed treatment comparison analysis of trial level data from 34 068 patient-years of follow-up from randomized trials. Circ Cardiovasc Interv. 2013 Aug; 6(4):378-90.
Score: 0.109
-
Response to letter regarding article, ?Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison Analysis of 117,762 patient-years of follow-up from randomized trials?. Circulation. 2013 Feb 12; 127(6):e447.
Score: 0.105
-
Drug-eluting versus bare-metal coronary stents: where are we now? J Comp Eff Res. 2012 Nov; 1(6):501-8.
Score: 0.103
-
Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials. BMJ. 2012 Aug 10; 345:e5170.
Score: 0.101
-
Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials. Circulation. 2012 Jun 12; 125(23):2873-91.
Score: 0.100
-
Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis. BMJ. 2013 Nov 08; 347:f6625.
Score: 0.028